Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.

Radiology

From the Department of Gastroenterology and Hepatology, Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, 37 Guoxue Ln, Chengdu 610041, China (X.W., G.L., J.W., X.X., Y.Y., Y.G., J.Y., L.Y., X. Luo); Department of Interventional Therapy, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (X. Li); and Department of Epidemiology and Medical Statistics, Department of Oncology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China (Y.H.).

Published: August 2023

AI Article Synopsis

  • Some research indicates that placing a transjugular intrahepatic portosystemic shunt (TIPS) early can improve survival for patients with severe variceal bleeding, but its effectiveness compared to other treatments like endoscopic variceal ligation (EVL) with propranolol is still unclear.
  • A study involving 100 participants was conducted to compare the effectiveness of an 8-mm TIPS against EVL plus propranolol in preventing rebleeding in advanced cirrhosis patients.
  • Results showed that while the TIPS group had a significantly lower risk of variceal rebleeding, they also experienced higher rates of hepatic encephalopathy, with no significant differences in overall survival between the two treatment

Article Abstract

Background Some studies have shown that transjugular intrahepatic portosystemic shunt (TIPS) placement within 72 hours of admission improves survival in patients at high risk who present with acute variceal bleeding. However, the role of small-diameter covered TIPS in the secondary prophylaxis of variceal bleeding is still debatable. Purpose To compare the efficacy of 8-mm TIPS and endoscopic variceal ligation (EVL) plus propranolol in the prevention of variceal rebleeding among participants with advanced cirrhosis. Materials and Methods Between June 2015 and December 2018, participants admitted to the hospital for variceal bleeding were considered for enrollment in this randomized controlled trial (ClinicalTrials.gov). Participants with Child-Pugh class B or C cirrhosis were randomly assigned to receive an 8-mm covered TIPS or EVL and propranolol. The primary end point was recurrent variceal bleeding assessed using Kaplan-Meier curve analysis. Secondary end points included survival and overt hepatic encephalopathy (HE) assessed using Kaplan-Meier curve analysis. Results A total of 100 participants were enrolled, with 50 randomly assigned to the EVL plus propranolol group (median age, 54 years; IQR, 45-60 years; 29 male, 21 female) and 50 randomly assigned to the TIPS group (median age, 49 years; IQR, 43-56 years; 32 male, 18 female). The median follow-up period was 43.4 months. In the TIPS group, variceal rebleeding risk was reduced compared with variceal rebleeding risk in the EVL plus propranolol group (hazard ratio [HR], 0.31; 95% CI: 0.14, 0.69; = .008), but the incidence of overt HE was higher in the TIPS group (30.0% vs 16.0%, = .03). No differences in survival were observed between the two groups (1-year survival: TIPS, 98.0%; EVL plus propranolol, 92.0%; 3-year survival: TIPS, 94.0%; EVL plus propranolol, 85.7%; HR, 0.52; 95% CI: 0.19, 1.42; = .22). Conclusion When compared with EVL plus propranolol, 8-mm TIPS led to reduced variceal rebleeding but did not impact overall survival in participants with Child-Pugh class B or C cirrhosis. Clinical trial registration no. NCT02477384 © RSNA, 2023 See also the editorial by Barth in this issue.

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.223201DOI Listing

Publication Analysis

Top Keywords

evl propranolol
28
variceal rebleeding
20
variceal bleeding
16
randomly assigned
12
tips group
12
variceal
11
tips
10
transjugular intrahepatic
8
intrahepatic portosystemic
8
portosystemic shunt
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!